The Indian stock market benchmark indices, Sensex and Nifty 50, traded lower on Tuesday, dragged by heavy selling across the board amid weak global cues. The benchmark Nifty 50 slipped below the key ...

Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international markets and new launches support the outlook. My updated fair value ...